| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Apr―28 |
Impact of COVID-19 and Non-Pharmaceutical Interventions on Common Respiratory Viruses in Children: A Five-Year Study in Hangzhou, China |
Jianming Zhou, Yanhong Sun, Hao Shen, Liaoqiao Yang, Qing Ye, Hongmei Zhu, Zhiwen Zhu |
| 2 |
[GO] |
2024―Nov―09 |
The fitness of molnupiravir-signed SARS-CoV-2 variants: imputation analysis based on prescription counts and GISAID analyses by country. |
Daniele Focosi, Dave McNally, Fabrizio Maggi |
| 3 |
[GO] |
2024―Aug―27 |
Efficacy and Clinical Outcomes of mRNA COVID-19 Vaccine in Pregnancy: A Systematic Review and Meta-Analysis |
Antonio J. Santimano, Raed M. Al-Zoubi, Ahmad R. Al-Qudimat, Mohamed B. Al Darwish, Laxmi Kumari Ojha, Mohamed Amine Rejeb, et al. (+10) Yasser Hamad, Malaz A. Elrashid, Noorah M. Ruxshan, Abdelfatteh El Omri, Hiba Bawadi, Maha A. Al-Asmakh, Aksam Yassin, Omar M. Aboumarzouk, Ahmad Zarour, Abdulla A. Al-Ansari |
| 4 |
[GO] |
2023―Dez―20 |
Impact of Age and Clinico-Biochemical Parameters on Clinical Severity of SARS-CoV-2 Infection |
Shariq Ahmad Wani, Babar Gulzar, Mosin Saleem Khan, Sabhiya Majid, Irfan Ahmad Bhat |
| 5 |
[GO] |
2023―Okt―11 |
Comparison of a Multiplex Real-Time PCR technique with Oxford Nanopore Technologies Next-Generation-Sequencing for identification of SARS-CoV-2 variants of concern |
Zahra Ahmadi, Ali Maleki, Sana Eybpoosh, Zahra Fereydouni, Mahsa Tavakoli, Setareh Kashanian, et al. (+3) Laya Asadi, Amir Hesam Nemati, Mostafa Salehi-Vaziri |
| 6 |
[GO] |
2023―Mrz―07 |
Evaluation of MicroRNAs expression pattern (miR-28, miR-181a, miR-34a, and miR-31) in Patients with COVID-19 Admitted to ICU, and Diabetic COVID-19 patients |
AliReza Khatami, Mohammad Taghizadieh, Javid Sadri Nahand, Mohammad Karimzadeh, Seyed Jalal Kiani, Khadijeh Khanaliha, et al. (+5) Saeed Kalantari, Sara Chavoshpour, Hamed Mirzaei, Tahereh Donyavi, Farah Bokharaei-Salim |
| 7 |
[GO] |
2022―Sep―14 |
Disinfection effect of hexadecyl pyridinium chloride on SARS-CoV-2 in vitro |
Ke-da Chen, Fei-ke Ma, Qing-jing Wang, Ying Wang, Xin-yi Zhuang, Xu-ning Zhang, et al. (+2) Hai-yan Mao, Yan-jun Zhang |
| 8 |
[GO] |
2022―Apr―04 |
SARS-COV-2 triggers the development of class I and class II HLA antibodies in recovered convalescent plasma donors |
Ashraf Dada, Khalid Elhassan, Rayan Mohammed Bawayan, Ghadeer Albishi, Lama Hefni, Sawsan Bassi, et al. (+6) Turki Sobahy, Edward Cupler, Nabeela AlBaz, Ghassan Wali, Basem Alraddadi, Abeer N. Alshukairi |
| 9 |
[GO] |
2022―Mrz―04 |
Latest insights on the diagnostic approaches and treatment strategies of COVID-19 |
Sarah S. Hassanein, Muhammed R. Sharaby, Noran M. Tawfik, Suzan A. Rashed, Mohamed Adel, Ayat Fayez, et al. (+2) Heba Mansour, Haitham M. Amer |
| 10 |
[GO] |
2022―Feb―22 |
Development of RNA-based assay for rapid detection of SARS-CoV-2 in clinical samples |
Vinod Kumar, Suman Mishra, Rajni Sharma, Jyotsna Agarwal, Ujjala Ghoshal, Tripti Khanna, et al. (+4) Lokendra K. Sharma, Santosh Kumar Verma, Prabhakar Mishra, Swasti Tiwari |
| 11 |
[GO] |
2022―Feb―08 |
Low risk of serological cross-reactivity between the dengue virus and SARS-CoV-2 IgG antibodies using advanced detection assays |
Farah M. Shurrab, Duaa W. Al-Sadeq, Fatima Humaira Amanullah, Enas S. Al-Absi, Hamda Qotba, Hadi M. Yassine, et al. (+2) Laith J. Abu-Raddad, Gheyath K. Nasrallah |
| 12 |
[GO] |
2021―Okt―19 |
The Features of Pathobiology and Clinical translation of Approved treatments for Coronavirus Disease 2019 (COVID-19) |
Hamidreza Abbasi, Hadi Razavi Nikoo, Ali Fallah, Azadeh Mohammad-Hasani, Abasalt Hosseinzadeh Colagar, Ayyoob Khosravi |
| 13 |
[GO] |
2021―Sep―20 |
Adverse Events Following AstraZeneca COVID-19 Vaccine in Saudi Arabia: A Cross-Sectional Study among Healthcare and Non-healthcare Workers |
Ahlam A. Alghamdi, Afrah Alkazemi, Abdulrahman Alissa, Isra Alghamdi, Ghadah Alwarafi, Hadeel A. Waggas |
| 14 |
[GO] |
2021―Jul―07 |
Seropositive reaction rates of 9 B cell epitopes of the SARS-CoV-2 spike protein and the relationship between the epitopes and neutralizing antibody |
Li Zhu, Yunwen Zhang, Zhengrong Yang, Baisheng Li, Tiejian Feng, Xuan Zou, et al. (+6) Jianfan He, Taiping He, Junling Li, Ning Liu, Wei Li, Xiaohui Wang |
| 15 |
[GO] |
2021―Jan―15 |
Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets |
Muhammad Tahir Khan, Muhammad Irfan, Hina Ahsan, Abrar Ahmed, Aman Chandra Kaushik, Anwar Sheed Khan, et al. (+3) Sathishkumar Chinnasamy, Arif Ali, Dong-Qing Wei |
| 16 |
[GO] |
2020―Dez―11 |
Available Antiretrovirals in the Treatment and Pre-Exposure Prophylaxis of SARS-CoV-2: Quo Vadis? |
Miguel Alpalhão, Paulo Filipe |
| 17 |
[GO] |
2020―Dez―09 |
Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis |
Mohitosh Biswas, Shawonur Rahaman, Tapash Kumar Biswas, Zahirul Haque, Baharudin Ibrahim |
| 18 |
[GO] |
2020―Okt―23 |
Understanding Severe Acute Respiratory Syndrome Coronavirus 2 Replication to Design Efficient Drug Combination Therapies |
Joseph T. Ortega, Jose L. Zambrano, Beata Jastrzebska, Ferdinando Liprandi, Hector R. Rangel, Flor H. Pujol |
|
